Stay updated on DTG/3TC in HIV-1 Adolescents Clinical Trial

Sign up to get notified when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DTG/3TC in HIV-1 Adolescents Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T06:16:16.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the introduction of a new study on the efficacy and safety of a fixed-dose combination of Dolutegravir and Lamivudine (DTG/3TC) for HIV-infected adolescents, while extensive details about previous regimens and study phases have been removed.
    Difference
    26%
    Check dated 2025-04-16T20:24:18.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T13:20:40.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-02T00:01:03.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-24T22:53:20.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T16:02:53.000Z thumbnail image

Stay in the know with updates to DTG/3TC in HIV-1 Adolescents Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DTG/3TC in HIV-1 Adolescents Clinical Trial page.